RescueMD

RescueMD sells physician-formulated skin-repair topicals that target post-procedure, scarred, sun-damaged and chronically inflamed skin. The line is small—three SKUs: a silicone-free scar + discoloration serum, a lipid-restoring barrier cream and a broad-spectrum SPF 50 mineral sunscreen—priced USD $42-$68, placing the brand in the mid-range dermaceutical tier. Distribution is DTC through rescuemd.com and a growing network of U.S. medical spas and plastic-surgery clinics; no mass retail. The brand’s technical edge is its patented peptide complex, Dalton-50, engineered to penetrate scar tissue and down-regulate inflammatory markers TGF-β and IL-6 while stimulating laminin-332 for faster re-epithelialization. Clinical data posted on the site show 72 % flattening and 68 % pigment reduction in 8-week post-laser patients. RescueMD positions itself as “post-procedure insurance”: medical-grade efficacy without prescription irritation, packaged in airless syringes that dispense exact 0.25 mL doses to prevent cross-contamination. Core buyers are 25-55-year-old women who regularly invest in energy-based treatments—CO₂, Morpheus8, microneedling—and want evidence-backed aftercare that shortens downtime and prevents PIH. The same demographic extends to C-section, orthopedic and cosmetic-surgery patients seeking scar optimization. Values are science-over-aesthetics, transparency (full ingredient decks, HIPAA-compliant tele-consults) and time-efficiency: multi-functional formulas that replace 3-4 separate post-proc products. RescueMD competes in the white-space between drugstore scar gels and high-price pharmaceutical growth factors. It differentiates by combining medical-device-level peptide delivery with clean-cosmetic sensibilities—no silicones, parabens or fragrance—while keeping unit cost under $0.90 per mL, roughly half that of comparable biotech serums.